Suzhou Basecare Medical Corporation Limited (Stock code: 2170) has been successfully listed on the Main board of the HKEX on 8 Feb 2021, the maximum fund raising size is HK$1824.01M. 

Suzhou Basecare Medical Corporation Limited is a China-based company principally engaged in the provision of genetic testing solutions for assisted reproduction and sales of genetic testing devices and instruments in China. The Company generates revenue mainly from distributed products, including noninvasive prenatal testing (NIPT) kits, metagenomic genetic detection (MGD) kits and testing devices and instruments, as well as self-developed products, mainly including PGT-A and CNV kits.
 
CBI is honoured to be engaged in providing Background search and Due Diligence service with regards to this listing application.